Health Supernova 2022 Health Supernova 2022
Get your ticket to attend. Join event to build your agenda.

Lightning Talk | Precision Pain Therapeutics

Room 104B

Candler Paige
Doloromics, CEO

Candler Paige, Ph.D. is a co-founder and the Chief Executive Officer of Doloromics. Doloromics has built a proprietary platform that identifies precision therapeutic targets and biomarkers for chronic pain. Currently, Doloromics is developing therapeutics against novel targets found through their work in human tissues. Prior to founding Doloromics, Candler received her Ph.D. in cognition and neuroscience from the University of Texas at Dallas where she received the prestigious NIH F99/K00 fellowship. Her dissertation work focused on identifying the mechanisms underlying the transition from acute to chronic pain in males and females. Candler has been an author of over 15 scientific journal articles and book chapters, presented numerous invited talks, and takes great pride in the undergraduate and graduate students she has mentored thus far. 

“No pain, no gain” is meant to console and motivate. Yet, for millions who live with unrelenting debilitating conditions, they’d do anything to gain relief. Opioids can’t be the only answer. Every day in America, three people die every hour from opioid overdose. Prescription opioid misuse alone costs the U.S. $78.5B a year for healthcare, addiction treatment, and more. Physicians need other options and other prospects to help patients manage their pain.

CEO Candler Paige is on a mission to help. Her company, Doloromics, is building a proprietary platform for discovery of disease-specific pain mechanisms, biomarkers, and therapeutics to treat inflammatory and chronic pain. It will be a game-changer for getting quick chronic pain relief to patients who suffer from migraine, muscle pain, and neuropathies — common problems that require uncommon solutions.